The Food and Drug Administration yesterday authorized the first COVID-19 antigen test that allows health care providers to read the results in minutes directly from the testing card, similar to some pregnancy tests.

Under the emergency use authorization, laboratories certified under the Clinical Laboratory Improvement Amendment to perform moderate, high or waived complexity tests and health care providers with a CLIA certificate of waiver, compliance or accreditation may use the test, made by Abbott Diagnostics Scarborough Inc. The company plans to make up to 50 million tests available monthly in the U.S. beginning in early October. 

Antigen tests are less sensitive than molecular tests, meaning negative results may need to be confirmed with a molecular test, FDA said.

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…